We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
–
AUM
$470M
AUM Growth
+$5.16M
Cap. Flow
-$4.49M
Cap. Flow %
-0.96%
Top 10 Hldgs %
34.1%
Holding
71
New
2
Increased
32
Reduced
28
Closed
2

Top Buys

Rank Stock Value
1
DEO icon
Diageo
DEO
+$6.29M
2
MRSH
Marsh
MRSH
+$6.06M
3
UNH icon
UnitedHealth
UNH
+$1.76M
4
AMGN icon
Amgen
AMGN
+$1.16M
5
EXPD icon
Expeditors International
EXPD
+$1.14M

Top Sells

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$14.5M
2
GILD icon
Gilead Sciences
GILD
+$7.53M
3
COL
Rockwell Collins
COL
+$1.06M
4
MA icon
Mastercard
MA
+$786K
5
CPRT icon
Copart
CPRT
+$614K

Sector Composition

Rank Sector Weight
1 Industrials 20.79%
2 Consumer Discretionary 20.25%
3 Technology 18.27%
4 Financials 14.9%
5 Healthcare 12.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
1
Mastercard
MA
$507B
$23.8M 5.07%
121,271
-4,179
-3% -$786K
MKC icon
2
McCormick & Company Non-Voting
MKC
$14B
$18.1M 3.86%
312,520
+18,350
+6% +$963K
CPRT icon
3
Copart
CPRT
$31.2B
$16.8M 3.59%
1,191,268
-45,336
-4% -$614K
AAPL icon
4
Apple
AAPL
$4.67T
$16.8M 3.57%
362,188
-5,824
-2% -$264K
MSFT icon
5
Microsoft
MSFT
$3.71T
$14.8M 3.15%
150,247
-5,245
-3% -$508K
SEIC icon
6
SEI Investments
SEIC
$13.2B
$14.4M 3.07%
230,564
+11,936
+5% +$794K
ACN icon
7
Accenture
ACN
$114B
$14.1M 3%
86,145
-1,269
-1% -$197K
ROL icon
8
Rollins
ROL
$17.3B
$14M 2.99%
600,482
-6,012
-1% -$136K
GGG icon
9
Graco
GGG
$12.6B
$14M 2.98%
309,369
-6,363
-2% -$292K
APH icon
10
Amphenol
APH
$204B
$13.3M 2.83%
1,219,064
-15,576
-1% -$169K
AMGN icon
11
Amgen
AMGN
$236B
$13M 2.77%
70,410
+6,544
+10% +$1.16M
TTC icon
12
Toro Company
TTC
$8.83B
$12.6M 2.68%
208,885
+1,223
+0.6% +$73.7K
CTSH icon
13
Cognizant
CTSH
$28.1B
$12.4M 2.65%
157,447
-2,944
-2% -$232K
GPN icon
14
Global Payments
GPN
$24.5B
$11.7M 2.49%
105,022
-862
-0.8% -$97.4K
TJX icon
15
TJX Companies
TJX
$145B
$11.6M 2.47%
243,824
-922
-0.4% -$40.5K
PEP icon
16
PepsiCo
PEP
$188B
$11.6M 2.47%
106,407
+9,853
+10% +$1.02M
ROST icon
17
Ross Stores
ROST
$73.7B
$11.5M 2.45%
135,723
-3,443
-2% -$280K
NKE icon
18
Nike
NKE
$57B
$11.3M 2.4%
141,343
-367
-0.3% -$25.9K
NEU icon
19
NewMarket
NEU
$8.14B
$11.1M 2.37%
27,516
+151
+0.6% +$59.1K
AON icon
20
Aon
AON
$68.5B
$11M 2.35%
80,498
+4,298
+6% +$606K
ORCL icon
21
Oracle
ORCL
$457B
$10.3M 2.19%
233,265
+1,700
+0.7% +$78.3K
PKG icon
22
Packaging Corp of America
PKG
$21.1B
$9.88M 2.1%
88,403
+555
+0.6% +$64.8K
EV
23
DELISTED
Eaton Vance Corp.
EV
$9.73M 2.07%
186,389
+9,876
+6% +$544K
DLX icon
24
Deluxe
DLX
$1.11B
$9.56M 2.03%
144,386
+4,326
+3% +$303K
VAR
25
DELISTED
Varian Medical Systems, Inc.
VAR
$9.55M 2.03%
84,011
+2,928
+4% +$350K
1
2 3

Similar funds

VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
QI
Qtron Investments Boston, Massachusetts $750M AUM 44.01% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
BCM
Bienville Capital Management New York $750M AUM 2.59% 1-Year Est. Return
BG
BDF Gestion Paris, France $747M AUM 47.35% 1-Year Est. Return
PCM
Permanent Capital Management Chicago, Illinois $747M AUM 17.94% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

JLB & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, JLB & Associates held 71 positions worth $470M, up 1.1% from $465M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

JLB & Associates's Q2 2018 filing shows 2 new, 32 increased, 28 reduced and 2 closed positions. Its largest new stake was UnitedHealth: 7,335 shares worth $1.8M. The largest sale was Keurig Dr Pepper, an estimated $14.5M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.

  • JLB & Associates's largest Q2 2018 buy was UnitedHealth: 7,335 shares worth $1.8M.
  • JLB & Associates added most to Diageo in Q2 2018, an estimated $6.29M increase.
  • JLB & Associates's biggest Q2 2018 reduction was Gilead Sciences, cutting an estimated $7.53M.
  • JLB & Associates fully exited Keurig Dr Pepper in Q2 2018, selling an estimated $14.5M.
  • JLB & Associates's ten largest holdings make up 34% of its $470M portfolio in Q2 2018.
  • JLB & Associates opened 2 new positions and closed 2 in Q2 2018.
  • JLB & Associates's portfolio value rose 1.1% quarter-over-quarter to $470M.

Based on JLB & Associates's 13F filing for Q2 2018, filed 9 Jul 2018.